This work was supported by Research Grant 96-2113-M-
003-004 from the National Science Council, Taiwan. We
are grateful to the National Center for High-performance
Computing of Taiwan for the electronic resources and facilities.
Notes and references
1 A. Radzicka and R. Wolfenden, Science, 1995, 267, 90–93.
2 J. K. Lee and K. N. Houk, Science, 1997, 276, 942–945.
3 B. P. Callahan and B. G. Miller, Bioorg. Chem., 2007, 35, 465–469.
4 B. G. Miller and R. Wolfenden, Annu. Rev. Biochem., 2002, 71,
847–885.
5 K. N. Houk, D. J. Tantillo, C. Stanton and Y. F. Hu, Top. Curr.
Chem., 2004, 238, 1–22.
6 T. P. Begley and S. E. Ealick, Curr. Opin. Chem. Biol., 2004, 8,
508–515.
7 M. Fujihashi, A. M. Bello, E. Poduch, L. H. Wei, S. C. Annedi,
E. F. Pai and L. P. Kotra, J. Am. Chem. Soc., 2005, 127,
15048–15050.
Scheme 5
8 S. Senda, K. Hirota and T. Asao, Tetrahedron Lett., 1973, 14,
2647–2650.
9 S. Senda, K. Hirota and T. Asao, Chem. Pharm. Bull., 1975, 23,
1708–1713.
10 S. Senda, K. Hirota and T. Asao, J. Org. Chem., 1975, 40, 353–356.
11 T.-C. Chien, C.-H. Jen, Y.-J. Wu and C.-C. Liao, Nucleic Acids
Symp. Ser., 2008, 52, 297–298.
12 J. G. Wittmann, D. Heinrich, K. Gasow, A. Frey, U. Diederichsen
and M. G. Rudolph, Structure, 2008, 16, 82–92.
13 D. Heinrich, U. Diederichsen and M. G. Rudolph, Chem.–Eur. J.,
2009, 15, 6619–6625.
Scheme 6
14 N. Wu and E. F. Pai, Top. Curr. Chem., 2004, 238, 23–42.
15 B. G. Miller, Top. Curr. Chem., 2004, 238, 43–62.
16 A. M. Bello, E. Poduch, M. Fujihashi, M. Amani, Y. Li,
I. Crandall, R. Hui, P. I. Lee, K. C. Kain, E. F. Pai and
L. P. Kotra, J. Med. Chem., 2007, 50, 915–921.
without the Lys residue in the active site, the K72A mutant
transformed 6-I-UMP (5) to BMP (4) which is similar to how
6-CN-UMP (3) was hydrolyzed by the wild-type MtODCase
(Scheme 1(B)(c)).
17 M. Fujihashi, L. H. Wei, L. P. Kotra and E. F. Pai, J. Mol. Biol.,
2009, 387, 1199–1210.
Our studies are in agreement with Kotra’s observations that
both 6-CN-1,3-DMU (7) and 6-Cl-1,3-DMU (15) underwent
ethanolysis in the presence of NaOAc, and that their reactions
with n-BuNH2 resulted in only 6-n-Bu-NH-1,3-DMU (9)
(summarized in Scheme 1(B) and Scheme 5). Furthermore,
in a competing experiment with a 1 : 1 mixture of both NaOAc
and n-BuNH2 in ethanol under reflux, to mimic the existence
of both Asp and Lys residues in the ODCase active site,
6-CN-1,3-DMU (7) only gave 6-EtO-1,3-DMU (16) while
6-Cl-1,3-DMU (15) predominantly afforded 6-n-Bu-NH-1,3-
DMU (9) (Scheme 6). The competing experiment has revealed
the distinct preferential reactivities of 6-CN-1,3-DMU (7) and
6-Cl-1,3-DMU (15), which could account for the different
transformations of 6-CN-UMP (3) and 6-I-UMP (5) catalyzed
by the same enzyme (Scheme 1(B), (a) & (d)).
18 (a) C. A. Lewis and R. Wolfenden, Biochemistry, 2009, 48,
8738–8745; (b) B. P. Callahan and R. Wolfenden, J. Am. Chem.
Soc., 2004, 126, 4514–4515; (c) A. Sievers and R. Wolfenden,
J. Am. Chem. Soc., 2002, 124, 13986–13987.
19 (a) F. M. Wong, C. C. Capule, D. X. Chen, S. Gronert and W. Wu,
Org. Lett., 2008, 10, 2757–2760; (b) F. Y. Yeoh, R. R. Cuasito,
C. C. Capule, F. M. Wong and W. Wu, Bioorg. Chem., 2007, 35,
338–343; (c) F. M. Wong and W. Wu, Bioorg. Chem., 2006, 34,
99–104; (d) F. M. Wong, C. C. Capule and W. Wu, Org. Lett.,
2006, 8, 6019–6022; (e) W. Y. Feng, T. J. Austin, F. Chew,
S. Gronert and W. Wu, Biochemistry, 2000, 39, 1778–1783;
(f) M. P. Nakanishi and W. Wu, Tetrahedron Lett., 1998, 39,
6271–6272; (g) W. Wu, A. Ley-han, F. M. Wong, T. J. Austin and
S. M. Miller, Bioorg. Med. Chem. Lett., 1997, 7, 2623–2628.
20 N. Wu, Y. R. Mo, J. L. Gao and E. F. Pai, Proc. Natl. Acad. Sci.
U. S. A., 2000, 97, 2017–2022.
21 D. A. Singleton, S. R. Merrigan, B. J. Kim, P. Beak, L. M. Phillips
and J. K. Lee, J. Am. Chem. Soc., 2000, 122, 3296–3300.
22 R. B. Silverman and M. P. Groziak, J. Am. Chem. Soc., 1982, 104,
6434–6439.
Our results from the chemical models may indicate that the
Asp residue in the active site could assume a role similar to
that of acetate in the chemical models. Thus, the model studies
suggest that the transformation of 6-CN-UMP (3) to BMP (4)
is catalyzed by MtODCase with the Asp residue as a general
base. While most of the model studies for ODCase have
focused on the explanation of transition state stablization
of the OMP decarboxylation,18–23 our chemical models have
established the role of the Asp residue in the ODCase active
site.24 It remains to be further investigated how the general
acid–base chemistry effects the decarboxylation of MtODCase.
23 P. Beak and B. Siegel, J. Am. Chem. Soc., 1976, 98, 3601–3606.
24 During the preparation of this manuscript, Rudolph et al. reported
that the cocrystallization of the human ODCase (hODCase)
with 6-CN-UMP (3) resulted in the presence of UMP (2) in the
active site, instead of BMP (4) ( ref. 13). The proposed mechanism
involved the hydrolysis of 6-CN-UMP (3) to OMP (1), followed by
a normal decarboxylation. In our model studies, we have observed
the formation of ethyl 1,3-dimethyluracil-6-carboxamidate (17) as
a by-product from the base-catalyzed ethanolysis (Table 1, entries
4, 5 and 7), and 1,3-dimethyluracil-6-carboxamide (13) as a result
of base-catalyzed hydrolysis. (Scheme 4) Accordingly, we antici-
pated that the Asp residue also plays the role of a general base for
the hODCase-catalyzed hydrolysis of 6-CN-UMP (3).
ꢀc
This journal is The Royal Society of Chemistry 2010
Chem. Commun., 2010, 46, 4821–4823 | 4823